摘要
目的比较丽珠肠乐（双歧杆菌活菌制剂）与酶诱导剂（鲁米那、尼可刹米）在治疗早期新生儿高胆红素血症的临床疗效。方法将92例早期新生儿高胆红素血症的病人随机分为治疗组49例．以丽珠肠乐（双歧杆菌活菌制剂350mg／d）配以蓝光照射治疗，对照组43例以酶诱导剂鲁米那5mg／（kg·d），尼可刹米100mg／（kg·d）并配以蓝光照射，总疗程5夭。结果治疗组显效率（77.6％）高于对照组（44.2％），P＜0.01。结论双歧杆菌活菌制剂治疗早期新生儿高胆红素血症优于酶诱导剂。
Objective To compare the effects of bifidobiogen with enzyme inductor(luminal, nikethamidum) in treatment early neonatal hyperbilirubinemia. Methods 92 babies with early neonatal hyperbilirubinemia were divided into 2 groups, randomly. 49 patients were treated with bifidobiogen 350 mg/(kg. d) and phototherapy. Other 43 patients were treated with enzyme lnductor luminal 5mg/(kg. d) ; nikethamidum 100mg/(kg. d)and phototherapy as the control group. Results The total effective rate in the treatment gr0up(77. 6% ) was higher than that in the control group (44. 2% ), P<0. 01. Conclusion Bifidobiogen is superior to enzyme inductor in treating early neonatal hyperbilirubinemia.
出处
《中国综合临床》
1999年第2期168-169,共2页
Clinical Medicine of China
